On the contrary, SOX9, SOX10, and SOX11 are upregulated in basal-like BC, indicating that therapeutic strategies targeting these factors may be beneficial for this subtype of cancer, which currently lacks targeted therapy. The gene discussed is SOX11; the disease is cancer.